by MiNDSET | Apr 21, 2026 | Studies & News |
What New Lancet Research Means for Depression Treatment Major depressive disorder (MDD) remains one of the most challenging mental health conditions to treat—particularly when patients experience suicidal thoughts. One of the greatest limitations in traditional care...
by MiNDSET | Nov 14, 2025 | Studies & News |
As a physician who has spent more than three decades treating patients with complex mental health and pain conditions, I know how urgently we need better solutions—especially for veterans living with PTSD, treatment-resistant depression, and anxiety disorders. That’s...
by MiNDSET | Oct 28, 2025 | Studies & News |
A major shift is underway. Health Canada has officially recognized ketamine as a National Priority Drug, marking a turning point in how this powerful therapy is understood and supported across the country. At MiNDSET Integrative Ketamine Care, we see this as more than...
by MiNDSET | Oct 22, 2025 | Studies & News |
What a New JAMA Study Reveals — and Why Integration Still Matters** In recent months, conversation around psychedelic medicine has shifted from curiosity to clinical seriousness. The latest editorial in JAMA — “Are Psychedelic Agents Ready for Prime Time as...
by MiNDSET | Aug 5, 2025 | Studies & News |
What Is Neuroplasticity? Neuroplasticity is the brain’s ability to reorganize itself by forming new neural connections throughout life. It’s how we learn new skills, form memories, and recover from trauma. In conditions like depression, anxiety, and PTSD,...
